454 related articles for article (PubMed ID: 27071030)
1. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
[TBL] [Abstract][Full Text] [Related]
2. The sequence analysis of Epstein-Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified?
Banko AV; Lazarevic IB; Karalic DZ; Djukic VB; Cupic MD; Stevanovic G; Jovanovic TP
Med Microbiol Immunol; 2019 Feb; 208(1):81-88. PubMed ID: 30203133
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
[TBL] [Abstract][Full Text] [Related]
4. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia.
Senyuta N; Yakovleva L; Goncharova E; Scherback L; Diduk S; Smirnova K; Maksimovich D; Gurtsevitch V
J Med Virol; 2014 Feb; 86(2):290-300. PubMed ID: 24009107
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
9. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
10. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
[TBL] [Abstract][Full Text] [Related]
11. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients.
Banko A; Lazarevic I; Cupic M; Stevanovic G; Boricic I; Jovanovic T
J Med Virol; 2012 Apr; 84(4):632-42. PubMed ID: 22337303
[TBL] [Abstract][Full Text] [Related]
12. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
13. [Characteristic of nuclear antigen 1 gene and latent membrane protein 1 gene of Epstein-Barr virus in primary EBV infection in children in Beijing area in 2005-2010].
Ai JH; Xie ZD; Liu CY; Gao LW; Yan J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Oct; 26(5):352-5. PubMed ID: 23547457
[TBL] [Abstract][Full Text] [Related]
14. Expression of Epstein Barr Virus Encoded EBNA1 and LMP1 Oncoproteins in Nasopharyngeal Carcinomas from Northeast India.
Borthakur P; Kataki K; Keppen C; Khamo V; Medhi S; Deka M
Asian Pac J Cancer Prev; 2016; 17(7):3411-6. PubMed ID: 27509984
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: a Tunisian report.
Hila L; Farah F; Ayari H; Ferjaoui M; Dehria W; Ben Jilani S
Pathol Biol (Paris); 2009 Jul; 57(5):427-9. PubMed ID: 18835109
[TBL] [Abstract][Full Text] [Related]
17. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
18. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
[TBL] [Abstract][Full Text] [Related]
19. Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity.
Tedeschi R; Pin E; Martorelli D; Bidoli E; Marus A; Pratesi C; Bortolin MT; Zanussi S; Vaccher E; Dolcetti R; De Paoli P
Clin Vaccine Immunol; 2007 Apr; 14(4):435-41. PubMed ID: 17329446
[TBL] [Abstract][Full Text] [Related]
20. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
